Torley Helen, PRES, reported a transaction classified as withholding at HALOZYME THERAPEUTICS, INC. involving 7098.000000 shares for an estimated $413742.42. Reported holdings after the transaction were 672738.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
PRESIDENT AND CEO
The reported disposition of 7,098 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
The reported disposition of 38,668 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
The reported disposition of 11,313 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
The reported disposition of 9,087 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer.
0 other filings
0 recent txs